Structural

Outcomes of Patients With New Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

18 min.

Atrioventricular Conduction System Changes During Transcatheter Aortic Valve Replacement (TAVR): Anatomic and Electrophysiologic Predictors of Heart Block in Prospective 400 Patient EPS/TAVR Study

22 min.

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

21 min.

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

10 min.

Cardiac Output, Cerebral Blood Flow and Cognitive Functioning in Patients Undergoing Transcatheter Aortic Valve Implantation

9 min.

Prophylactic Antithrombotic Therapy After TAVR

12 min.

Pharmacotherapy to Slow AS Progression and Protect the Heart

9 min.

EARLY TAVR

5 min.

EVOLVED: CMR As an Early Marker of Risk

6 min.

Moderate AS With Heart Failure: TAVR UNLOAD

4 min.

Moderate AS With Cardiac Damage: The PROGRESS Trial

5 min.

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

8 min.

TAVR vs SAVR in Low Gradient AS: Evidence Updates

18 min.

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

17 min.

Importance of Patient Reported Outcomes

14 min.

An Echo Deep Dive of the PARTNER 5-Year Study

13 min.

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

18 min.

Perspectives on Mortality in the PARNTER 5-Year Study

15 min.

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

16 min.

Four-Year Outcomes From the EVOLUT Low Risk Trial

19 min.

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

23 min.

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

12 min.

Moderate AS With Heart Failure: UNLOAD and Beyond

9 min.

Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-To-Edge Repair: Insights from the TriValve Registry

9 min.

SPOTLIGHT LECTURE: Failed TAVR Management -Lessons Learned From Registry Experiences

14 min.

Clinical Data for the ACURATE Platform

16 min.

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

14 min.

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

15 min.

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

17 min.

Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

8 min.

Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies

9 min.

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

14 min.

SPOTLIGHT LECTURE Staging of Aortic Stenosis According to Cardiac Dysfunction: Recent Updates

17 min.

Using CMR Imaging to Identify High-Risk Severe AS Patients (Introduction to the EVOLVED Study)

5 min.

Sensor-Guided TAVR Initial experience with the SavvyWire: Post-Market Registry of the First 60 Cases

7 min.

Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

18 min.

SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments

8 min.

ShortCut Dedicated Aortic Leaflet Splitting Device: Clinical Experience and Emerging Indications

14 min.

Can Scoring the Calcified Aortic Valve Defer the Need for Permanent Implant (Leaflex): Technology and Clinical Update

12 min.

Aortic Valve Lithotripsy Before TAVR: Early Human Clinical Experience

6 min.

TAVR Explant: What Every Interventionalist (and Surgeon) Needs to Know

8 min.

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

8 min.

Surgical ADVANCEMENTS in Aortic Valve Regurgitation: When to… Repair vs. Ross vs. Replace with Root Management?

10 min.

Intersection of Guidelines and Clinical practice : Meaningful Guardrails Provide a Necessary Framework

7 min.

Update on the Evidence – Registries are Enough

6 min.

Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies

10 min.